blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3701970

EP3701970 - IMMUNITY-BOOSTING AGENT, IMMUNO-THERAPEUTIC ANTI-CANCER AGENT, AND ANTI-CANCER THERAPY ADVERSE EFFECT MITIGATING AGENT CONTAINING ANTHOCYANIN-FUCOIDAN COMPLEX AS ACTIVE INGREDIENT [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  31.07.2020
Database last updated on 08.10.2024
FormerThe international publication has been made
Status updated on  04.05.2019
Most recent event   Tooltip03.08.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
JBKLAB Co., Ltd.
Dream Techno Sangdaewon-dong
2nd Floor
464 Dunchon-daero
Jungwon-gu
Seongnam-si, Gyeonggi-do 13229 / KR
[2020/36]
Inventor(s)01 / JANG, Bong Keun
102-1006, 375, Jungbu-daero
Giheung-gu
Yongin-si, Gyeonggi-do 17064 / KR
 [2023/15]
Former [2020/36]01 / NA, Kun
A-1302
7 Oksan-ro
Bucheon-si Gyeonggi-do 14574 / KR
02 / JANG, Bong Keun
102-1006
375 Jungbu-daero
Giheung-gu
Yongin-si Gyeonggi-do 17064 / KR
03 / JO, Young-Um
703-1001
19 Manyang-ro
Dongjak-gu
Seoul 06920 / KR
04 / SEO, Jeong Deok
155-17 Gwanggeumbuk-ro 114beon-gil
Hongdong-myeon
Hongseong-gun Chungcheongnam-do 32283 / KR
05 / LEE, Joo Young
No. 401
53 Wagae-gil
Danwon-gu
Ansan-si Gyeonggi-do 15266 / KR
Representative(s)Roos, Peter
c/o Roospatent
Noldinstrasse 7
81545 München / DE
[2020/36]
Application number, filing date18870322.726.10.2018
[2020/36]
WO2018KR12849
Priority number, dateKR2017014118427.10.2017         Original published format: KR 20170141184
[2020/36]
Filing languageKO
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2019083328
Date:02.05.2019
Language:KO
[2019/18]
Type: A2 Application without search report 
No.:EP3701970
Date:02.09.2020
Language:EN
[2020/36]
Search report(s)International search report - published on:KR27.06.2019
(Supplementary) European search report - dispatched on:EP26.07.2021
ClassificationIPC:A61K47/61, A61K31/352, A23L33/105, A23L33/125, A61P35/00, A61K45/06, A61K36/73, A61K31/737, A61K31/704
[2021/34]
CPC:
A61K31/737 (EP,US); A61K47/61 (EP,KR,US); A61K36/73 (EP,KR,US);
A23L33/105 (EP,KR); A23L33/125 (EP,KR); A61K31/352 (EP);
A61K31/704 (EP); A61K45/06 (EP); A61P35/00 (EP,KR,US);
A61P37/02 (KR); A23V2002/00 (EP,KR); A23V2200/308 (KR);
A23V2200/324 (KR); A23V2250/2104 (KR); A23V2250/51 (KR) (-)
C-Set:
A61K31/352, A61K2300/00 (EP);
A61K31/704, A61K2300/00 (EP);
A61K31/737, A61K2300/00 (EP);
A61K36/73, A61K2300/00 (EP);
A23V2002/00, A23V2200/308, A23V2200/324, A23V2250/2104, A23V2250/51 (EP)
(-)
Former IPC [2020/36]A61K47/61, A61K31/352, A23L33/105, A23L33/125
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/36]
TitleGerman:IMMUNITÄTSVERSTÄRKENDES MITTEL, IMMUNTHERAPEUTISCHES ANTIKREBSMITTEL UND MITTEL ZUR ABSCHWÄCHUNG DER ANTIKREBSTHERAPIENEBENWIRKUNG MIT ANTHOCYANIN-FUCOIDAN-KOMPLEX ALS WIRKSTOFF[2020/36]
English:IMMUNITY-BOOSTING AGENT, IMMUNO-THERAPEUTIC ANTI-CANCER AGENT, AND ANTI-CANCER THERAPY ADVERSE EFFECT MITIGATING AGENT CONTAINING ANTHOCYANIN-FUCOIDAN COMPLEX AS ACTIVE INGREDIENT[2020/36]
French:AGENT DE STIMULATION DE L'IMMUNITÉ, AGENT ANTI-CANCÉREUX IMMUNO-THÉRAPEUTIQUE, ET AGENT D'ATTÉNUATION D'EFFETS INDÉSIRABLES DE LA THÉRAPIE ANTICANCÉREUSE CONTENANT UN COMPLEXE ANTHOCYANINE-FUCOÏDANE EN TANT QUE PRINCIPE ACTIF[2020/36]
Entry into regional phase25.05.2020Translation filed 
27.05.2020National basic fee paid 
27.05.2020Search fee paid 
27.05.2020Designation fee(s) paid 
27.05.2020Examination fee paid 
Examination procedure27.05.2020Examination requested  [2020/36]
18.01.2022Amendment by applicant (claims and/or description)
Fees paidRenewal fee
05.09.2020Renewal fee patent year 03
27.10.2021Renewal fee patent year 04
31.10.2022Renewal fee patent year 05
26.10.2023Renewal fee patent year 06
02.08.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]KR20150066004  (HAERIMFUCOIDAN CO LTD [KR]) [A] 1-12 * See the entire document. *;
 [A]KR20130130573  (NAT UNIV GYEONGSANG IACF [KR]) [A] 1-12 * See the entire document. *;
 [A]KR20120000388  (KOREA NAT OPEN UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION [KR]) [A] 1-12 * See the entire document. *
 [XY]  - MIN, D. H. et al., "Fucoidan Based Nanocomplex for Improving Antioxidant Activity of Anthocyanin", Biomaterials Research, (20120000), vol. 16, no. 2, pages 60 - 66, XP055621220 [X] 1-3, 9-12 * See abstract; pages 60-62, 65. * [Y] 4-8
 [Y]  - CHOUNG, M. G. et al., "Antioxidant, Anticancer and Immune Activation of Anthocyanin Fraction from Rubus Coreanus Miquel Fruits (Bokbunja", Korean J. Medicinal Crop Sci., (20120000), vol. 20, no. 4, doi:10.7783/KJMCS.2012.20.4.259, pages 259 - 269, XP053030799 [Y] 4-8 * See pages 266-267. *

DOI:   http://dx.doi.org/10.7783/KJMCS.2012.20.4.259
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.